Pharmaniaga Berhad, a prominent player in the pharmaceutical industry, is headquartered in Malaysia (MY) and operates extensively across Southeast Asia. Founded in 1994, the company has established itself as a leading provider of generic pharmaceuticals, over-the-counter products, and healthcare solutions.
With a commitment to quality and innovation, Pharmaniaga offers a diverse range of products, including prescription medications and vaccines, which are distinguished by their adherence to stringent regulatory standards. The company has achieved significant milestones, including partnerships with government health agencies and a robust distribution network that enhances its market position.
Recognised for its contributions to public health, Pharmaniaga continues to expand its footprint, ensuring access to essential medicines while maintaining a focus on sustainability and community welfare.
+5 vs industry average
Pharmaniaga’s score of 32 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pharmaniaga?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Pharmaniaga's reported carbon emissions
Pharmaniaga Berhad, headquartered in Malaysia (MY), has disclosed its greenhouse gas emissions for several reporting years. For the 2025 reporting year, the company's total emissions, encompassing Scope 1, 2, and 3, are approximately 127,451,000 kg CO2e. This includes Scope 1 emissions of about 5,468,590 kg CO2e, Scope 2 emissions of approximately 31,796,690 kg CO2e, and Scope 3 emissions of roughly 89,207,190 kg CO2e.
In the 2024 reporting year, Pharmaniaga reported Scope 1 emissions of approximately 5,610,630 kg CO2e and Scope 2 emissions of about 30,328,970 kg CO2e. Scope 3 data was not disclosed for this year.
For the 2023 reporting year, Scope 1 emissions were approximately 6,576,490 kg CO2e, and Scope 2 emissions were around 29,081,550 kg CO2e. Similar to 2024, Scope 3 emissions were not reported.
The company's climate commitments and reduction targets are not detailed in the provided information.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Pharmaniaga’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Pharmaniaga yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Pharmaniaga
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project